SLC7A11 and gastric cancer: Pharmacological inhibition of SLC7A11 with sulfasalazine (SSZ) or erastin, genetic silencing of SLC7A11 expression, or inhibition of GSH synthesis with buthionine sulphoximine (BSO) restores cisplatin sensitivity in gastric cancer cells [85].